Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation

BACKGROUND: Warfarin is the most prescribed oral anticoagulant used for preventing stroke in patients with atrial fibrillation. Time in the therapeutic range (TTR) has been accepted as the best method to evaluate the quality of warfarin therapy. The main aim of the present study was to evaluate the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Marcatto, Leiliane Rodrigues, Sacilotto, Luciana, da Costa Darrieux, Francisco Carlos, Hachul, Denise Tessariol, Scanavacca, Maurício Ibrahim, Krieger, Jose Eduardo, Pereira, Alexandre Costa, Lima Santos, Paulo Caleb Junior
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper: Gerotarget (Focus on Aging)
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342334/
https://ncbi.nlm.nih.gov/pubmed/27486984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10944
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia